Approval · Notice of Compliance 16562 · 2015
ALKERAN: Notice of Compliance 16562
Issued January 23, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16562
- Date
- January 23, 2015
- Company
- Aspen Pharma Trading Limited
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
- Therapeutic class
- Antineoplastic (alkylating) agent
Products in this notice
Medicinal ingredients
- MELPHALAN 2 MG per TAB
- BUFFER SOLUTION 10 ML per VIAL
- MELPHALAN HCL 50 MG per VIAL